Saydam, G. Et Al. 2016. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase. Expert Opinion on Pharmacotherapy , vol.17, no.14 , 1851-1858.

Saydam, G., Haznedaroglu, I. C., Kaynar, L., Yavuz, A. S., Ali, R., Guvenc, B., ... Akay, O. M.(2016). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase. Expert Opinion on Pharmacotherapy , vol.17, no.14, 1851-1858.

Saydam, Guray Et Al. "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase," Expert Opinion on Pharmacotherapy , vol.17, no.14, 1851-1858, 2016

Saydam, Guray Et Al. "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase." Expert Opinion on Pharmacotherapy , vol.17, no.14, pp.1851-1858, 2016

Saydam, G. Et Al. (2016) . "Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase." Expert Opinion on Pharmacotherapy , vol.17, no.14, pp.1851-1858.

@article{article, author={Guray Saydam Et Al. }, title={Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase}, journal={Expert Opinion on Pharmacotherapy}, year=2016, pages={1851-1858} }